ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 15.12 Delayed Data As of 4:00pm ET |  -0.155 / -1.02%Today’s Change | 12.24 Today|||52-Week Range 28.06 | -35.24% Year-to-Date |
Latest ACAD News | Press Releases
No recent news for ACADIA Pharmaceuticals Inc.
Today’s Trading
| Previous close | 15.27 |
| Today’s open | 15.17 |
| Day’s range | 14.99 - 15.56 |
| Volume | 122,824 |
| Average volume (3 months) | 2,308,197 |
| Market cap | $2.3B |
Data as of 4:00pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | +41.56% |
| Earnings growth (this year) | -31.94% |
| Earnings growth (next 5 years) | +55.91% |
| Revenue growth (last year) | +9.60% |
| P/E ratio | NM |
| Price/Sales | 7.74 |
| Price/Book | 4.27 |
Competitors
| ---- | ||
| HCMHUTCHMED (China) Ltd | -0.51 | -3.50% |
| INSMInsmed Inc | +0.77 | +3.62% |
| PCRXPacira Biosciences I... | -0.68 | -1.17% |
Data as of 3:59pm ET, 07/06/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $484.1M |
| Annual profit (last year) | -$167.9M |
| Net profit margin | -34.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
